Glutamate and glutathione interplay in a motor neuronal model of amyotrophic lateral sclerosis reveals altered energy metabolism

Neurobiology of Disease

Volumn 43, Issue 2, 2011, Pages 346-355

  D'Alessandro, Giuseppina ^a   Calcagno, Eleonora ^a   Tartari, Silvia ^a   Rizzardini, Milena ^a   Invernizzi, Roberto William ^a   Cantoni, Lavinia ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Cu,Zn superoxide dismutase; Glutamate; Glutaminase; Glutamine; Glutathione; Motor neuron; NSC 34 cells; Pyruvate dehydrogenase kinase l

Indexed keywords

3 HYDROXYBUTYRIC ACID; COPPER ION; CYSTEINE; CYTOSOLIC MALATE DEHYDROGENASE; GLUCOSE; GLUTAMIC ACID; GLUTAMINASE; GLUTATHIONE; LACTIC ACID; MALATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE KINASE; PYRUVATE DEHYDROGENASE KINASE 1; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ZINC ION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME SUBSTRATE; MOTONEURON; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL COMMUNICATION; CELL LINE; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; GLUTAMIC ACID; GLUTATHIONE; HUMANS; MICE; MICE, TRANSGENIC; MITOCHONDRIAL DISEASES; MODELS, NEUROLOGICAL; MOTOR NEURONS;

EID: 79958239154     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.04.003     Document Type: Article

References (54)

1. Aoyama K., Watabe M., Nakaki T. Regulation of neuronal glutathione synthesis. J Pharmacol Sci 2008, 108:227-238.
2. Babetto E., Mangolini A., Rizzardini M., Lupi M., Conforti L., Rusmini P., et al. Tetracycline-regulated gene expression in the NSC-34-tTA cell line for investigation of motor neuron diseases. Brain Res Mol Brain Res 2005, 140:63-72.
3. Barber S.C., Shaw P.J. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med 2010, 48:629-641.
4. Basso M., Samengo G., Nardo G., Massignan T., D'Alessandro G., Tartari S., et al. Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis. PLoS One 2009, 4:e8130.
5. Bergmayer H.U. Malate dehydrogenase. Methods of enzymatic analysis 1974, Vol. 1:485. Academic Press, Inc., New York. H.U. Bergmayer (Ed.).
6. Bhaskar P.T., Nogueira V., Patra K.C., Jeon S.M., Park Y., Robey R.B., et al. mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3β inhibition. Mol Cell Biol 2009, 29:5136-5147.
7. Brasse-Lagnel C., Lavoinne A., Husson A. Control of mammalian gene expression by amino acids, especially glutamine. FEBS J 2009, 276:1826-1844.
8. Browne S.E., Yang L., Di Mauro J.P., Fuller S.W., Licata S.C., Beal M.F. Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS. Neurobiol Dis 2006, 22:599-610.
9. Ceglia I., Carli M., Baviera M., Renoldi G., Calcagno E., Invernizzi R.W. The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC. J Neurochem 2004, 91:189-199.
10. Chi L., Ke Y., Luo C., Gozal D., Liu R. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo. Neuroscience 2007, 144:991-1003.
11. Choi J.K., Küstermann E., Dedeoglu A., Jenkins B.G. Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation. Eur J Neurosci 2009, 30:2143-2150.
12. De la Rosa V., Campos-Sandoval J.A., Martín-Rufián M., Cardona C., Matés J.M., Segura J.A., et al. A novel glutaminase isoform in mammalian tissues. Neurochem Int 2009, 55:76-84.
13. Diaz-Hernandez J.I., Almeida A., Delgado-Esteban M., Fernandez E., Bolaños J.P. Knockdown of glutamate-cysteine ligase by small hairpin RNA reveals that both catalytic and modulatory subunits are essential for the survival of primary neurons. J Biol Chem 2005, 280:38992-39001.
14. Dupuis L., Corcia P., Fergani A., Gonzalez De Aguilar J.L., Bonnefont-Rousselot D., Bittar R., et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 2008, 70:1004-1009.
15. Ferri A., Cozzolino M., Crosio C., Nencini M., Casciati A., Gralla E.B., et al. Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials. Proc Natl Acad Sci USA 2006, 103:13860-13865.
16. Frigerio F., Casimir M., Carobbio S., Maechler P. Tissue specificity of mitochondrial glutamate pathways and the control of metabolic homeostasis. Biochim Biophys Acta 2008, 1777:965-972.
17. Gutmann I., Wahlefeld A.W. L-(+)-lactate. Determination with lactate dehydrogenase and NAD. Methods of Enzymatic Analysis 1974, Vol. 3:1464-1468. Academic Press, Inc., New York. H.U. Bergmayer (Ed.).
18. Haces M.L., Hernández-Fonseca K., Medina-Campos O.N., Montiel T., Pedraza-Chaverri J., Massieu L. Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions. Exp Neurol 2008, 211:85-96.
19. Han J., Ma L. Study of the features of proton MR spectroscopy ((1)H-MRS) on amyotrophic lateral sclerosis. J Magn Reson Imaging 2010, 31:305-308.
20. Harraz M.M., Marden J.J., Zhou W., Zhang Y., Williams A., Sharov V.S., et al. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest 2008, 118:659-670.
21. Hernandez-Fonseca K., Cardenas-Rodriguez N., Pedraza-Chaverri J., Massieu L. Calcium-dependent production of reactive oxygen species is involved in neuronal damage induced during glycolysis inhibition in cultured hyppocampal neurons. J Neurosci Res 2008, 86:1768-1780.
22. Herrero-Mendez A., Almeida A., Fernández E., Maestre C., Moncada S., Bolaños J.P. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat Cell Biol 2009, 11:747-752.
23. Jang H.J., Kwak J.H., Cho E.Y., We Y.M., Lee Y.H., Kim S.C., et al. Glutamine induces heat-shock protein-70 and glutathione expression and attenuates ischemic damage in rat islets. Transplant Proc 2008, 40:2581-2584.
24. Kashiwaya Y., Takeshima T., Mori N., Nakashima K., Clarke K., Veech R.L. d-β-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci USA 2000, 97:5440-5444.
25. Kim J.W., Tchernyshyov I., Semenza G.L., Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006, 3:177-185.
26. Kita K., Sato M., Suzuki T., Ochi T. Structure-effect relationship in the down-regulation of glutaminase in cultured human cells by phenylarsenic compounds. Toxicology 2009, 258:157-163.
27. Kranich O., Hamprecht B., Dringen R. Different preferences in the utilization of amino acids for glutathione synthesis in cultured neurons and astroglial cells derived from rat brain. Neurosci Lett 1996, 219:211-214.
28. Lee J.I., Dominy J.E., Sikalidis A.K., Hirschberger L.L., Wang W., Stipanuk M.H. HepG2/C3A cells respond to cysteine deprivation by induction of the amino acid deprivation/integrated stress response pathway. Physiol Genomics 2008, 33:218-229.
29. Lu H., Dalgard C.L., Mohyeldin A., McFate T., Tait A.S., Verma A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J Biol Chem 2005, 280:41928-41939.
30. Lund T.M., Risa O., Sonnewald U., Schousboe A., Waagepetersen H.S. Availability of neurotransmitter glutamate is diminished when β-hydroxybutyrate replaces glucose in cultured neurons. J Neurochem 2009, 110:80-91.
31. Mali Y., Zisapel N. VEGF up-regulation by G93A superoxide dismutase and the role of malate-aspartate shuttle inhibition. Neurobiol Dis 2010, 37:673-681.
32. McGowan J.E., Chen L., Gao D., Trush M., Wei C. Increased mitochondrial reactive oxygen species production in newborn brain during hypoglycemia. Neurosci Lett 2006, 399:111-114.
33. McKenna M.C., Waagepetersen H.S., Schousboe A., Sonnewald U. Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools. Biochem Pharmacol 2006, 71:399-407.
34. Moncada S., Bolaños J.P. Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 2006, 97:1676-1689.
35. Niessen H.G., Debska-Vielhaber G., Sander K., Angenstein F., Ludolph A.C., Hilfert L., et al. Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Eur J Neurosci 2007, 25:1669-1677.
36. Palaiologos G., Hertz L., Schousboe A. Evidence that aspartate aminotransferase activity and ketodicarboxylate carrier function are essential for biosynthesis of transmitter glutamate. J Neurochem 1988, 51:317-320.
37. Pedersen W.A., Mattson M.P. No benefit of dietary restriction on disease onset or progression in amyotrophic lateral sclerosis Cu/Zn-superoxide dismutase mutant mice. Brain Res 1999, 833:117-120.
38. Pehar M., Vargas M.R., Robinson K.M., Cassina P., Díaz-Amarilla P.J., Hagen T.M., et al. Mitochondrial superoxide production and nuclear factor erythroid 2-related factor 2 activation in p75 neurotrophin receptor-induced motor neuron apoptosis. J Neurosci 2007, 27:7777-7785.
39. Peng L., Gu L., Zhang H., Huang X., Hertz E., Hertz L. Glutamine as an energy substrate in cultured neurons during glucose deprivation. J Neurosci Res 2007, 85:3480-3486.
40. Raimondi A., Mangolini A., Rizzardini M., Tartari S., Massari S., Bendotti C., et al. Cell culture models to investigate the selective vulnerability of motoneuronal mitochondria to familial ALS-linked G93ASOD1. Eur J Neurosci 2006, 24:387-399.
41. Ramos M., del Arco A., Pardo B., Martínez-Serrano A., Martínez-Morales J.R., Kobayashi K., et al. Developmental changes in the Ca2+-regulated mitochondrial aspartate-glutamate carrier aralar1 in brain and prominent expression in the spinal cord. Brain Res Dev Brain Res 2003, 143:33-46.
42. Rizzardini M., Lupi M., Bernasconi S., Mangolini A., Cantoni L. Mitochondrial dysfunction and death in motor neurons exposed to the glutathione-depleting agent ethacrynic acid. J Neurol Sci 2003, 207:51-58.
43. Rothstein J.D. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 2009, 65(Suppl 1):S3-S9.
44. Shi Q., Xu H., Kleinman W.A., Gibson G.E. Novel functions of the α-ketoglutarate dehydrogenase complex may mediate diverse oxidant-induced changes in mitochondrial enzymes associated with Alzheimer's disease. Biochim Biophys Acta 2008, 1782:229-238.
45. Starkov A.A., Fiskum G., Chinopoulos C., Lorenzo B.J., Browne S.E., Patel M.S., et al. Mitochondrial α-ketoglutarate dehydrogenase complex generates reactive oxygen species. J Neurosci 2004, 24:7779-7788.
46. Sutherland G.R., Tyson R.L., Auer R.N. Truncation of the Krebs cycle during hypoglycemic coma. Med Chem 2008, 4:379-385.
47. Tartari S., D'Alessandro G., Babetto E., Rizzardini M., Conforti L., Cantoni L. Adaptation to G93Asuperoxide dismutase 1 in a motor neuron cell line model of amyotrophic lateral sclerosis: the role of glutathione. FEBS J 2009, 276:2861-2874.
48. Tieu K., Perier C., Caspersen C., Teismann P., Wu D.C., Yan S.D., et al. d-β-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J Clin Invest 2003, 112:892-901.
49. Todorova V.K., Kaufmann Y., Hennings L., Klimberg V.S. Oral glutamine protects against acute doxorubicin-induced cardiotoxicity of tumor-bearing rats. J Nutr 2010, 140:44-48.
50. Van Den Bosch L., Van Damme P., Bogaert E., Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta 2006, 1762:1068-1082.
51. Vogel R., Wiesinger H., Hamprecht B., Dringen R. The regeneration of reduced glutathione in rat forebrain mitochondria identifies metabolic pathways providing the NADPH required. Neurosci Lett 1999, 275:97-100.
52. Waagepetersen H.S., Qu H., Sonnewald U., Shimamoto K., Schousboe A. Role of glutamine and neuronal glutamate uptake in glutamate homeostasis and synthesis during vesicular release in cultured glutamatergic neurons. Neurochem Int 2005, 47:92-102.
53. Zaman K., Ryu H., Hall D., O'Donovan K., Lin K.I., Miller M.P., et al. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin. J Neurosci 1999, 19:9821-9830.
54. Zhao Z., Lange D.J., Voustianiouk A., MacGrogan D., Ho L., Suh J., et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci 2006, 7:29.